ARTICLE | Company News
Seattle Genetics, Astellas deal
December 7, 2009 8:00 AM UTC
Seattle Genetics and Astellas' Agensys Inc. subsidiary added additional targets to a 2007 deal to develop and commercialize antibody-drug conjugates (ADCs) for cancer. Seattle Genetics has the option ...